Life Science Executive Partnering
Congress Sept 16-17, Forums Sept 15, 2025Thomas Michael Menino Convention & Exhibition Center, Boston, USA Lucas BonDurrantPrinciple Scientist at AlnylamSpeaker
Profile
Dr. Lucas BonDurant is a motivated drug hunter with a passion for developing novel siRNA-based therapeutics for both rare and common cardiometabolic diseases. He has led multiple cross functional teams to develop various assets beginning with early target ideation and preclinical validation through development candidate selection. Through leadership and collaboration, he has overseen multiple candidates progress through the clinic being tested in diverse indications such as MASLD, dyslipidemia, type 2 diabetes and obesity.
Agenda Sessions
siRNA-based Therapeutics Targeting INHBE and ACVR1C Obesity-Driving Genes
, 11:35amView Session